Search

Update on the importance of children and pregnant women attending immunisation appointments during the coronavirus (COVID-19) outbreak.

Steven Barron, Jane-Claire Judson, Rak Nandwani and Liz Humphreys have been reappointed as Members of the Public Health Scotland (PHS) Board.

Public Health Scotland has launched its first strategic plan.

Representatives from across Scotland’s housing sector will join a virtual webinar, hosted by the Scottish Federation of Housing Associations (SFHA), on the impact of childhood adverse experiences (ACEs) and trauma within the housing sector on 28th October.

Following the discovery of a data coding issue which led to a number of people across Scotland being mistakenly invited for a shingles or pneumococcal vaccine, Public Health Scotland (PHS) has been leading the response.

The data published today show that PHS has received reports of six new IGAS cases between 5 and 11 December across all age groups in Scotland, with no new reports in children under 10 years since last week’s report. Although increases in GAS have been reported in recent weeks in Scotland, the more serious Invasive GAS (IGAS) infections remain stable and similar to previous years.

Public Health Scotland has published the latest childhood immunisation report describing the uptake rates for children in Scotland to the end of March 2023.

The work undertaken by Health Protection Scotland continues within Public Health Scotland with no break in service as a result of the move.

Public Health Scotland (PHS) is supporting the 16 Days of Activism against Gender-Based Violence campaign which launches today. Violence against women and girls (VAWG) is a major...

The main findings of this year’s Scottish Multiple Sclerosis Register (SMSR) report are that 578 new patients diagnosed with Multiple Sclerosis (MS) were added to the Register and despite the challenges of the pandemic, the proportion of newly-diagnosed people in contact with an MS specialist nurse within 10 working days of diagnosis increased to 88. 2%.